230 results on '"Durot, Eric"'
Search Results
2. Cerebellum/liver index on baseline 18F-FDG PET/CT to improve prognostication in post-transplant lymphoproliferative disorders: a multicenter retrospective study
3. Advances in Treatment of Waldenström Macroglobulinemia
4. Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases
5. Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma
6. Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5′RACE
7. High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma
8. Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group
9. Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia
10. A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML
11. Simplified Risk Stratification Model for Patients With Waldenström Macroglobulinemia
12. Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients
13. High efficacy of CD19 CAR T-cells in patients with transformed Waldenström macroglobulinemia
14. Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study
15. 18F-FDG cerebellum/liver index as a prognostic factor for progression-free survival in diffuse large B-cell lymphoma
16. Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers
17. A revised international prognostic score system for Waldenström’s macroglobulinemia
18. Dosage of high‐dose methotrexate as CNS prophylaxis in DLBCL: A detailed analysis of toxicity and impact on CNS relapse.
19. Cutaneous relapses location in diffuse large B-cell lymphoma leg type after immunochemotherapy
20. Pretreatment CT Texture Parameters as Predictive Biomarkers of Progression-Free Survival in Follicular Lymphoma Treated with Immunochemotherapy and Rituximab Maintenance
21. 18FDG PET/CT in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type
22. Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and Rituximab
23. Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients
24. Born in the UK : A registry to improve and broadcast knowledge on Waldenström macroglobulinaemia
25. Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients
26. O-127 - Cutaneous relapses location in diffuse large B-cell lymphoma leg type after immunochemotherapy
27. High PDL1/PDL2gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma
28. Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA
29. Transformed Waldenström Macroglobulinemia: Update on Diagnosis, Prognosis and Treatment
30. P-169: Bendamustine rituximab primary therapy for Waldenström Macroglobulinemia: an international, multicenter collaborative study
31. “Double‐hit” chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain
32. Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi‐institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO)
33. Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma
34. High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia
35. Bendamustine rituximab (BR) versus ibrutinib (Ibr) as primary therapy for Waldenström macroglobulinemia (WM): An international collaborative study.
36. High frequency of central nervous system involvement in transformed Waldenstrom macroglobulinemia
37. Recovery of full donor chimerism with ibrutinib therapy in relapsed CLL after allogeneic stem cell transplantation
38. Computed Tomography-Based Texture Analysis as a Predictor of Survival in Patients with T-Cell Lymphomas.
39. Cerebellum/liver index in pretherapeutic 18F-FDG PET/CT as a predictive marker of progression-free survival in follicular lymphoma treated by immunochemotherapy and rituximab maintenance
40. Germany and the French Wars of Religion, 1560-1572 « St Andrews studies in Reformation History » van Tol Jonas
41. Le prédicant, hérétique et séditieux. De l'édit de Compiègne (1557) à l'édit de janvier (1562)
42. François de Lorraine (1520-1563) : duc de Guise et nouveau Roi mage
43. Le crépuscule de l'Auld Alliance : la légitimité du pouvoir en question entre Écosse, France et Angleterre (1558-1561)
44. Salvage Therapy with Brentuximab-Vedotin and Bendamustine for Patients with Relapsed/Refractory T Cell Lymphoma. a Multicenter and Retrospective Study
45. Nivolumab First-Line Therapy for Elderly, Frail Hodgkin Lymphoma Patients: Niviniho, a Lysa Phase II Study
46. A Phase II Study of the Efficacy and Tolerance of Azacytidine (AZA) in Steroid Dependent/Refractory Systemic Autoimmune and Inflammatory Disorders (SAID) Associated with MDS or CMML (GFM- AZA-SAID -trial)
47. High Frequency of CNS Involvement in Transformed Waldenström Macroglobulinemia
48. Early Integration of High Dose Methotrexate to Frontline DLBCL Therapy Does Not Impact CNS Relapse Compared to End of Treatment Delivery: A Multicentre International Analysis of 1384 Patients
49. Watch and wait in Waldenström macroglobulinaemia: looking for who to watch carefully and who can wait without worrying. Is it that simple?
50. Platinum and high-dose cytarabine-based regimens are efficient in ultra high/high-risk chronic lymphocytic leukemia and Richterʼs syndrome: results of a French retrospective multicenter study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.